Kotra Industries Bhd's EBIT per Share for the
three
months ended in Mar. 2026 was RM0.07.
Its EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 was RM0.32.
During the past 12 months, the average EBIT per Share Growth Rate of Kotra Industries Bhd was -14.50% per year.
During the past 3 years, the average EBIT per Share Growth Rate was -4.10% per year.
During the past 5 years, the average EBIT per Share Growth Rate was 16.10% per year.
During the past 10 years, the average EBIT per Share Growth Rate was 24.70% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
The historical rank and industry rank for Kotra Industries Bhd's EBIT per Share or its related term are showing as below:
XKLS:0002'
s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -31 Med: 9 Max: 75.4
Current: -4.1
During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of Kotra Industries Bhd was 75.40% per year. The lowest was -31.00% per year. And the median was 9.00% per year.
XKLS:0002's 3-Year EBIT Growth Rate is ranked worse than 67.99% of 809
companies
in the Drug Manufacturers industry
Industry Median: 7.6
vs XKLS:0002: -4.10
Kotra Industries Bhd (XKLS:0002) EBIT per Share Explanation
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
Kotra Industries Bhd EBIT per Share Related Terms
Kotra Industries Bhd EBIT per Share Historical Data
* Premium members only.
The historical data trend for Kotra Industries Bhd's EBIT per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was RM0.32
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Kotra Industries Bhd (XKLS:0002) has a EBIT per Share of RM0.32 as of Mar. 2026. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Kotra Industries Bhd and its competitors. According to the industry distribution chart, Kotra Industries Bhd ranks #550 out of 809 companies in the Drug Manufacturers industry, placing it in the top 68%.
Is Kotra Industries Bhd's EBIT per Share too high?
Kotra Industries Bhd's current EBIT per Share is RM0.32. Based on the distribution chart, Kotra Industries Bhd ranks #550 out of 809 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Kotra Industries Bhd has a GF Score™ of 84/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Kotra Industries Bhd's EBIT per Share compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Kotra Industries Bhd ranks #550 out of 809 companies for EBIT per Share. This places Kotra Industries Bhd in the lower half of its industry. The industry median EBIT per Share is 7.60. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for a Drug Manufacturers company?
The median EBIT per Share among Drug Manufacturers companies is 7.60, based on 809 companies in the industry. Companies in the top quartile (top 25%) have a EBIT per Share significantly above this median, while those in the bottom quartile fall well below. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Kotra Industries Bhd and its competitors. For the Drug Manufacturers industry, the median EBIT per Share is 7.60 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Kotra Industries Bhd's current EBIT per Share is RM0.32. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kotra Industries Bhd stock overvalued right now?
Based on GuruFocus' analysis, Kotra Industries Bhd (XKLS:0002) is currently considered Modestly Undervalued. The stock's GF Value™ is RM4.34, compared to a current price of RM3.73 — trading 14.1% below its estimated fair value. The current EBIT per Share is RM0.32. Kotra Industries Bhd's overall GF Score™ is 84/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For Kotra Industries Bhd (XKLS:0002), the current EBIT per Share is RM0.32 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Kotra Industries Bhd (XKLS:0002) Overvalued in 2026?
Based on GuruFocus' analysis, Kotra Industries Bhd stock appears to be undervalued.
The current stock price of RM3.73 is trading 14.1% below its estimated GF Value™ of RM4.34.
GuruFocus considers Kotra Industries Bhd to be Modestly Undervalued.
Key valuation signals for XKLS:0002:
EBIT per Share: RM0.32
GF Value™: RM4.34 vs. price of RM3.73 (14.1% below fair value)
No single metric tells the full story. See the XKLS:0002 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Kotra Industries Bhd is a Malaysian pharmaceutical company engaged in the development, manufacturing, and supply of pharmaceutical and healthcare products supporting all life stages. Its portfolio includes life-saving medicines, OTC supplements, and nutrition products. The Group markets three core brands: Appeton, offering health supplements and nutrition across all age groups; Vaxcel, providing injectable medicines for infectious diseases, kidney care, and gastroenterology; and Axcel, specializing in oral and topical medicines for paediatrics, dermatology, and infectious diseases. The company operates in Malaysia and overseas, with the majority of revenue derived from Malaysia.
84GF Score
Get the complete analysis for XKLS:0002
EBIT per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XKLS:0002 has been successfully added to your 
